Search
for
Sort by
Research 30 of 51
- Ox40-Cre–mediated deletion of BRD4 reveals an unexpected phenotype of hair follicle stem cells in alopecia
- Identification of A p300–SP1–BRD4 Transcriptional Axis as a Key Driver of AR Hyperactivation in Polycystic Ovarian Syndrome
- Charting the Bromodomain BRD4: Towards the Identification of Novel Inhibitors with Molecular Similarity and Receptor Mapping
- Oncogenic senescence: a multi-functional perspective
- 575 INTASYL self-delivering RNAi: A flexible platform to treat dermatological malignancies
- Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
- Identifying the Target Cells and Mechanisms of Merkel Cell Polyomavirus Infection
- Honokiol protects skin cells against inflammation, collagenolysis, apoptosis, and senescence caused by cigarette smoke damage
- Molecular pathology of skin adnexal tumours
- γδ17 T cell-stromal networks modulate matrix composition and vascularity in foreign body response
- Progress on genome-wide association studies and selection signature analysis for agronomic traits in Chinese sheep and goats: review
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Cellular Plasticity in Cutaneous Wound Healing
- Selection signatures of wool color in Gangba sheep revealed by genome-wide SNP discovery
- Emerging Strategies in Smart Nano-PROTAC for Stimuli-Responsive Protein Degradation and Precision Cancer Therapy
- ELL Facilitates RNA Polymerase II–Mediated Transcription of Human Epidermal Proliferation Genes
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- Biological Function of Long Non-coding RNA (LncRNA) Xist
- Roles of the Hedgehog Signaling Pathway in Epidermal and Hair Follicle Development, Homeostasis, and Cancer
- Functional Enhancers As Master Regulators of Tissue-Specific Gene Regulation and Cancer Development.
- NDA Submission of Vepdegestrant (ARV-471) to U.S. FDA: The Beginning of a New Era of PROTAC Degraders
- PROTACs: A novel strategy for cancer drug discovery and development
- Is There a Histone Code for Cellular Quiescence?
- Merkel cell carcinoma: updates in tumor biology, emerging therapies, and preclinical models
- Class IIa HDAC4 and HDAC7 cooperatively regulate gene transcription in Th17 cell differentiation
- YAP/TAZ Signalling Controls Epidermal Keratinocyte Fate
- Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
- Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
- Proteolysis‐Targeting Chimera (PROTAC): Current Applications and Future Directions
- Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers